Related Experiment Video
Updated: Jul 17, 2025

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Revisiting JC virus and progressive multifocal leukoencephalopathy
Angela Rocchi1, Ilker K Sariyer2, Joseph R Berger3
1Department of Microbiology, Immunology and Inflammation, Center for Neurovirology and Gene Editing, Temple University Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA.
Abstract:
Since its definition 65 years ago, progressive multifocal leukoencephalopathy (PML) has continued to devastate a growing population of immunosuppressed patients despite major advances in our understanding of the causative JC virus (JCV). Unless contained by the immune system, JCV lyses host oligodendrocytes collateral to its life cycle, leading to demyelination, neurodegeneration, and death. Novel treatments have stagnated in the absence of an animal model while current antiviral agents fail to address the now ubiquitous polyomavirus. In this review, we highlight the established pathogenesis by which JCV infection progresses to PML, highlighting major challenges that must be overcome to eliminate the underlying virus and, therefore, the debilitating disease.
Insights
Progressive multifocal leukoencephalopathy (PML) devastates immunosuppressed patients due to JC virus (JCV) lysis of oligodendrocytes. Overcoming JCV pathogenesis and developing new treatments are crucial for combating this debilitating neurological disease.
Area of Science:
- Neurovirology
- Immunology
- Neuropathology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease affecting immunosuppressed individuals.
- The disease is caused by the JC virus (JCV), a ubiquitous polyomavirus.
- JCV infects and lyses oligodendrocytes, leading to neurodegeneration and often death.
Purpose of the Study:
- To review the established pathogenesis of JCV infection leading to PML.
- To highlight the significant challenges hindering the development of effective treatments.
- To emphasize the need for novel therapeutic strategies against JCV.
Main Methods:
- This is a review article, synthesizing existing knowledge on PML and JCV.
- It examines the established mechanisms of JCV pathogenesis.
- It discusses challenges in antiviral development and the lack of animal models.
Main Results:
- JCV pathogenesis involves oligodendrocyte lysis, causing demyelination and neurodegeneration.
- Current antiviral treatments are ineffective against JCV.
- The absence of a suitable animal model impedes therapeutic research.
Conclusions:
- Understanding JCV pathogenesis is key to combating PML.
- Overcoming challenges in antiviral development is essential.
- Novel therapeutic approaches are urgently needed to eliminate JCV and treat PML.
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Retroviruses
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

